Remogliflozin (Remo), an inhibitor of the sodiumglucose cotransporter 2 (SGLT2) protein, is one of the most recently developed antidiabetic drugs for treating type 2 diabetes mellitus (T2DM)
Tavafi M (2013) Diabetic nephropathy and antioxidants
Normal blood levels range from 96-106 mEq/L
Delivery Mechanism Studies : Investigating device-based administration parameters and release kinetics for combined peptide formulations in vitro
Approximately one-third of cases are asymptomatic ( Unlike common schwannomas, MMNST is prone to local recurrence and displays metastatic potential ( Our review on SSP-MMNST demonstrated metastasis occurrence in 31.58% of cases, with male prevalence (66.6%) and with no statistically significant difference from the metastatic rate of spinal MMNST (p=0.463) ( In 83% of cases of metastasis, the primitive tumor developed in the lumbar region with a slightly greater risk in males (RR=1.45, p=0.608)
Importantly, correcting a deficiency helps restore normal function